GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Other Current Receivables

Y-Biologics (XKRX:338840) Other Current Receivables : ₩319 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Other Current Receivables?

Y-Biologics's Other Current Receivables for the quarter that ended in Mar. 2024 was ₩319 Mil.

Y-Biologics's quarterly Other Current Receivables declined from Sep. 2023 (₩105.44 Mil) to Dec. 2023 (₩58.47 Mil) but then increased from Dec. 2023 (₩58.47 Mil) to Mar. 2024 (₩319.05 Mil).

Y-Biologics's annual Other Current Receivables declined from Dec. 2020 (₩4,417.23 Mil) to Dec. 2021 (₩1,245.70 Mil) and declined from Dec. 2021 (₩1,245.70 Mil) to Dec. 2022 (₩200.60 Mil).

Y-Biologics Other Current Receivables Historical Data

The historical data trend for Y-Biologics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Other Current Receivables Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Receivables
Get a 7-Day Free Trial 348.52 375.27 4,417.23 1,245.70 200.60

Y-Biologics Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only 869.41 150.92 105.44 58.47 319.05

Y-Biologics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Y-Biologics Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics (XKRX:338840) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Other Current Receivables
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR
Website
https://www.ybiologics.com
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines